Clinical Trial Update: A Multi-Center, Open-Label Study [Phase 1]

View source ↗

Summary

This document reports a Phase 1, multi-center open-label study sponsored by Chelsea Therapeutics that has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Snippet

Sponsor: Chelsea Therapeutics | Conditions: Renal Disease, End Stage Renal Disease | Phase 1 | Status: WITHDRAWN